MX351365B - Gránulos para preparaciones farmacéuticas, métodos y aparatos para su producción. - Google Patents

Gránulos para preparaciones farmacéuticas, métodos y aparatos para su producción.

Info

Publication number
MX351365B
MX351365B MX2014011350A MX2014011350A MX351365B MX 351365 B MX351365 B MX 351365B MX 2014011350 A MX2014011350 A MX 2014011350A MX 2014011350 A MX2014011350 A MX 2014011350A MX 351365 B MX351365 B MX 351365B
Authority
MX
Mexico
Prior art keywords
granules
pharmaceutical preparations
methods
production
preparations
Prior art date
Application number
MX2014011350A
Other languages
English (en)
Inventor
Carsten Hoeg-Moller
Crilles Casper Larsen
Jorgen Wittendorff
Brigitte Nissen
Kenneth Manby Pedersen
Tue Hansen
Helle Poulsen
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42110308&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX351365(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of MX351365B publication Critical patent/MX351365B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/609—Amides, e.g. salicylamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se dan a conocer preparaciones farmacéuticas, granulares, mejoradas, junto con métodos y aparatos mejorados para la preparación de gránulos para el uso en estas preparaciones. Estos métodos son especialmente útiles para hacer gránulos para preparaciones farmacéuticas de dosis orales sólidas y son particularmente adecuados para la producción de gránulos que comprenden ácido 5- aminosalicílico (5-ASA) para el tratamiento de la enfermedad inflamatoria intestinal. Los gránulos exhiben una distribución de longitud con picos más agudos, y por lo tanto una distribución de relación entre dimensiones, y consecuentemente tienen un perfil de disolución mucho más agudo después del procesamiento adicional. La figura más representativa de la invención es la número 1a.
MX2014011350A 2009-12-18 2010-12-15 Gránulos para preparaciones farmacéuticas, métodos y aparatos para su producción. MX351365B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09179877A EP2340812A1 (en) 2009-12-18 2009-12-18 Granules for pharmaceutical preparations, methods and apparatus for their production
PCT/EP2010/069733 WO2011073245A2 (en) 2009-12-18 2010-12-15 Granules for pharmaceutical preparations, methods and apparatus for their production

Publications (1)

Publication Number Publication Date
MX351365B true MX351365B (es) 2017-10-12

Family

ID=42110308

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014011350A MX351365B (es) 2009-12-18 2010-12-15 Gránulos para preparaciones farmacéuticas, métodos y aparatos para su producción.
MX2012006851A MX2012006851A (es) 2009-12-18 2010-12-15 Granulos para preparaciones farmceuticas, metodos y aparatos para su produccion.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2012006851A MX2012006851A (es) 2009-12-18 2010-12-15 Granulos para preparaciones farmceuticas, metodos y aparatos para su produccion.

Country Status (27)

Country Link
US (2) US8765185B2 (es)
EP (2) EP2340812A1 (es)
JP (1) JP5593396B2 (es)
KR (1) KR101882880B1 (es)
CN (2) CN102791257B (es)
AR (1) AR079536A1 (es)
AU (1) AU2010332884B2 (es)
BR (1) BR112012014935B1 (es)
CA (1) CA2784235C (es)
DK (1) DK2512453T3 (es)
ES (1) ES2612870T3 (es)
HR (1) HRP20161639T1 (es)
HU (1) HUE031228T2 (es)
IL (1) IL220319A (es)
JO (1) JO3762B1 (es)
LT (1) LT2512453T (es)
MX (2) MX351365B (es)
NL (1) NL1038373C2 (es)
NZ (1) NZ600582A (es)
PL (1) PL2512453T3 (es)
PT (1) PT2512453T (es)
RS (1) RS55438B1 (es)
RU (1) RU2584349C2 (es)
SI (1) SI2512453T1 (es)
TW (1) TWI511723B (es)
WO (1) WO2011073245A2 (es)
ZA (1) ZA201204441B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1615619A2 (en) * 2003-04-23 2006-01-18 Ferring B.V. Sachet for a pharmaceutical composition
WO2010040020A1 (en) 2008-10-02 2010-04-08 Salix Pharmaceuticals, Ltd. Methods of treating hepatic encephalopathy
EP2340812A1 (en) 2009-12-18 2011-07-06 Ferring International Center S.A. Granules for pharmaceutical preparations, methods and apparatus for their production
US20140141075A1 (en) 2012-11-21 2014-05-22 Warner Chilcott Company, Llc 5-aminosalicylic acid capsule formulation
DE202017102645U1 (de) * 2017-05-03 2018-08-06 Romaco Kilian Gmbh Ablaufvorrichtung für Presslinge einer Rundläufer-Tablettenpresse sowie Rundläufer-Tablettenpresse mit Ablaufvorrichtung
RU2667637C1 (ru) * 2017-06-26 2018-09-21 Гермес Арцнаймиттель ГмбХ Фармацевтическая композиция для перорального применения, содержащая n-ацетилцистеин с маскированным вкусом
ES2938608T3 (es) 2017-09-20 2023-04-13 Tillotts Pharma Ag Método para preparar una forma farmacéutica sólida que comprende anticuerpos mediante granulación en húmedo, extrusión y esferonización
EP3459529A1 (en) 2017-09-20 2019-03-27 Tillotts Pharma Ag Preparation of sustained release solid dosage forms comprising antibodies by spray drying
EP3459528B1 (en) 2017-09-20 2022-11-23 Tillotts Pharma Ag Preparation of solid dosage forms comprising antibodies by solution/suspension layering
KR102161235B1 (ko) * 2020-07-22 2020-09-29 주식회사 피티케이 이송 일체형 과립 제조 장치 및 방법
CN114472139A (zh) * 2022-01-04 2022-05-13 安徽宏信药业发展有限公司 一种中药药丸干燥筛选装置
CN115445902B (zh) * 2022-09-21 2023-06-06 重庆科技学院 一种条形颗粒物三维尺寸分选方法及装置
CN116942532B (zh) * 2023-09-20 2023-12-12 北京爱力佳医药科技有限公司 一种粉状药物制备装置

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002671A1 (en) 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
DE3786544T2 (de) 1986-03-10 1994-02-03 Cri Int Inc Verfahren zur Sortierung und Isolierung von Katalysator-Formteilchen nach ihrer Länge.
US4720473A (en) * 1986-03-10 1988-01-19 Cri International, Inc. Production of improved catalyst-type particles using length and density grading
JPH0827133B2 (ja) 1993-07-13 1996-03-21 不二パウダル株式会社 湿潤粉粒体の処理装置
US6004581A (en) * 1995-12-21 1999-12-21 Farmaceutisk Laboratorium Ferring A/S Modified release oral pharmaceutical composition and method for the treatment of bowel diseases
TR199801158T2 (xx) 1995-12-21 1998-09-21 Farmaceutisk Laboratorium Ferring A/S Ba��rsak hastal�klar� i�in oral farmas�tik kompozisyon.
AUPO637197A0 (en) 1997-04-23 1997-05-15 F.H. Faulding & Co. Limited Taste-masked pharmaceutical compositions
DE19724181A1 (de) * 1997-06-09 1998-12-10 Bayer Ag Multiple-unit-retard-Zubereitungen und Verfahren zu ihrer Herstellung
JP2000128774A (ja) 1998-10-26 2000-05-09 Tanabe Seiyaku Co Ltd 薬物を含有する球形微粒子の製法
US6146685A (en) 1998-11-05 2000-11-14 Delsys Pharmaceutical Corporation Method of deposition a dry powder and dispensing device
WO2000044353A1 (de) * 1999-01-29 2000-08-03 Losan Pharma Gmbh Pharmazeutische zusammensetzungen
US6735487B1 (en) 1999-07-01 2004-05-11 Ods Properties, Inc. Interactive wagering system with promotions
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
CN100506234C (zh) 2001-10-15 2009-07-01 凡林有限公司 用于治疗溃疡性结肠炎和克罗恩病的含有5-氨基水杨酸的药物组合物的制备方法
AR036797A1 (es) 2001-10-15 2004-10-06 Ferring Bv Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
US7445796B2 (en) 2002-08-19 2008-11-04 L. Perrigo Company Pharmaceutically active particles of a monomodal particle size distribution and method
EP1615619A2 (en) 2003-04-23 2006-01-18 Ferring B.V. Sachet for a pharmaceutical composition
EP1470819A1 (en) * 2003-04-23 2004-10-27 Ferring B.V. High drug load mesalazine sachet
EP1547601A1 (en) 2003-12-23 2005-06-29 Ferring B.V. Coating method
US7207505B2 (en) 2004-06-04 2007-04-24 Bender Martin P Method for producing small granules
DE102004028977A1 (de) * 2004-06-16 2006-01-05 Add Advanced Drug Delivery Technologies Ltd. Neutralpellets
WO2007061717A2 (en) 2005-11-17 2007-05-31 Teva Pharmaceutical Industries, Ltd. Methods for isolating propargylated aminoindans
EP2340812A1 (en) 2009-12-18 2011-07-06 Ferring International Center S.A. Granules for pharmaceutical preparations, methods and apparatus for their production

Also Published As

Publication number Publication date
MX2012006851A (es) 2012-08-31
US9114083B2 (en) 2015-08-25
US20130022681A1 (en) 2013-01-24
US8765185B2 (en) 2014-07-01
US20140328934A1 (en) 2014-11-06
AR079536A1 (es) 2012-02-01
PL2512453T3 (pl) 2017-03-31
TW201125556A (en) 2011-08-01
ZA201204441B (en) 2013-02-27
JO3762B1 (ar) 2021-01-31
TWI511723B (zh) 2015-12-11
WO2011073245A2 (en) 2011-06-23
RU2012124834A (ru) 2014-01-27
EP2340812A1 (en) 2011-07-06
JP2013514312A (ja) 2013-04-25
BR112012014935A2 (pt) 2016-03-08
IL220319A (en) 2016-03-31
NL1038373C2 (en) 2011-06-21
EP2512453A2 (en) 2012-10-24
AU2010332884B2 (en) 2015-12-10
DK2512453T3 (en) 2017-01-09
CA2784235A1 (en) 2011-06-23
WO2011073245A3 (en) 2011-08-11
ES2612870T3 (es) 2017-05-19
BR112012014935B1 (pt) 2021-12-21
IL220319A0 (en) 2012-08-30
PT2512453T (pt) 2016-12-16
NZ600582A (en) 2014-09-26
KR20120102775A (ko) 2012-09-18
CN105769772A (zh) 2016-07-20
RS55438B1 (sr) 2017-04-28
KR101882880B1 (ko) 2018-07-27
JP5593396B2 (ja) 2014-09-24
RU2584349C2 (ru) 2016-05-20
CN102791257B (zh) 2017-03-01
LT2512453T (lt) 2016-12-27
CN102791257A (zh) 2012-11-21
HUE031228T2 (en) 2017-07-28
HRP20161639T1 (hr) 2017-02-10
CA2784235C (en) 2019-01-15
AU2010332884A1 (en) 2012-07-05
EP2512453B1 (en) 2016-11-09
SI2512453T1 (sl) 2017-02-28

Similar Documents

Publication Publication Date Title
MX2012006851A (es) Granulos para preparaciones farmceuticas, metodos y aparatos para su produccion.
IL222120A (en) Annals (indole-1-yl) -carbonylalkyl, process for preparation, pharmaceutical preparations containing them and their use in the preparation of cancer drugs
AP3438A (en) Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
IL223795A (en) History of Tetrahydro-Pyrido-Pyrimidine
NZ592325A (en) Extended release oral acetaminophen/tramadol dosage form
MY178082A (en) Solid pharmaceutical compositions and processes for their production
SG196810A1 (en) Controlled release pharmaceutical or foodformulation and process for its preparation
IL215826A (en) Pharmaceutical preparation with delayed release, process of preparation of the preparation, use of the preparation for the preparation of pain medication and the pill containing it.
EA201490653A1 (ru) Производные эстра-1,3,5(10),16-тетраен-3-карбоксамида, способ их получения, содержащие их фармацевтические препараты, а также их применение для получения лекарственных средств
IL217036A (en) Salt is attached to acetylsalicylic acid, its uses in the preparation of drugs, its pharmaceutical compositions and an integrated medical product that includes the salt of this acid
IL203936A (en) HISTORY 4 - Pyrimidinsulfamide, Process for Preparation, Pharmaceutical Preparations Containing and Using it for Medication Preparation
PH12015500823A1 (en) Modified release formulations for oprozomib
HUE038174T2 (hu) Eljárás citromsavat, magnéziumoxidot, káliumbikarbonátot és nátriumpikoszulfátot tartalmazó gyógyszertermék elõállítására, ilyen eljárással elõállított szemcsés gyógyászati készítmény és köztitermékei
FR2937972B1 (fr) Derives d'oxoazetidine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
IL213983A (en) Derivatives of pyridazinone that are converted into heteroaryl, their process, their pharmaceutical preparations and their use in the preparation of drugs
HRP20161796T1 (hr) Farmaceutski pripravak za primjenu u tretmanu ili prevenciji deficijencije vitamina i minerala kod pacijenata podvrgnutih operaciji želučane premosnice
UA112767C2 (uk) Фармацевтичний препарат, що містить селеніт або селенітвмісні сполуки, для лікування дисплазій або карцином шийки матки
MX337488B (es) Granulos con alto contenido de ibuprofeno sodico, su preparacion y su uso en preparar formas de dosificacion solidas no efervescentes.
MX2015006217A (es) Tableta dispersable.
EP2058300A4 (en) AMMONIC ACID DIEDERATE DERIVATIVE, METHOD FOR THE PRODUCTION AND THE USE OF THE DERIVATIVE PRODUCTION OF PREPARATION OF PHARMACEUTICAL PRODUCTS
EP2431049A4 (en) Pharmaceutical preparation for administration to the respiratory system Prevention of inflammatory respiratory diseases and methods of treatment or PREVENTION OF SUCH DISEASES
MX2018011685A (es) Proceso para formulaciones solidas de mesalazina.
CN104511018B (zh) 一种改善左卡尼汀片强吸湿性和溶出行为的处方和工艺
Agarwal et al. formulation, evaluation and comparision of dissolution profiles of Eslicarbazepine acetate immediate release tablets using natural binders against synthetic binder
MX2011009846A (es) Formulaciones galenicas de una combinacion de dosis fija de valsartan y alisquireno.